Identification of a secretory protein c19orf10 activated in hepatocellular carcinoma
Hajime Sunagozaka(Kouseiren Takaoka Hospital), Shuichi Kaneko(Kanazawa University)
Cited by 24
Related Papers
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|436
Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria
|Journal of Biological Chemistry|2009|428
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.
|Proceedings of the National Academy of Sciences|1989|303